Monoclonal Antibody to Osteopontin (OPN)
SPP1; BNSP; BSPI; ETA1; Secreted Phosphoprotein 1; Bone Sialoprotein I; Early T-Lymphocyte Activation 1; Nephropontin; Urinary stone protein; Uropontin
- Product No.MAA899Hu22
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- SourceMonoclonal antibody preparation
- HostMouse
- Potency (Clone Number)C1
- Ig Isotype IgG1 Kappa
- PurificationProtein A + Protein G affinity chromatography
- LabelNone
- Immunogen RPA899Hu02-Recombinant Osteopontin (OPN)
- Buffer FormulationPBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
- TraitsLiquid
- Concentration1mg/ml
- Organism Species Moren/a
- ApplicationsWB; IHC; ICC; IP.
If the antibody is used in flow cytometry, please check FCM antibodies. - Download Instruction Manual
- UOM 20µl100µl 200µl 1ml 10ml
-
FOB
US$ 87
For more details, please contact local distributors!US$ 203
For more details, please contact local distributors! US$ 290
For more details, please contact local distributors! US$ 725
For more details, please contact local distributors! US$ 2900
For more details, please contact local distributors!
SPECIFITY of the Monoclonal Antibody to Osteopontin (OPN)
The antibody is a mouse monoclonal antibody raised against OPN. It has been selected for its ability to recognize OPN in immunohistochemical staining and western blotting.
USAGE of the Monoclonal Antibody to Osteopontin (OPN)
Western blotting: 0.01-2µg/mL
Immunohistochemistry: 5-20µg/mL
Immunocytochemistry: 5-20µg/mL
Optimal working dilutions must be determined by end user.
STORAGE of the of the Monoclonal Antibody to Osteopontin (OPN)
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY of the Monoclonal Antibody to Osteopontin (OPN)
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
GIVEAWAYS
INCREMENT SERVICES
Antibody Labeling Customized Service
Protein A/G Purification Column
Staining Solution for Cells and Tissue
Positive Control for Antibody
Tissue/Sections Customized Service
Phosphorylated Antibody Customized Service
Western Blot (WB) Experiment Service
Immunohistochemistry (IHC) Experiment Service
Immunocytochemistry (ICC) Experiment Service
Flow Cytometry (FCM) Experiment Service
Immunoprecipitation (IP) Experiment Service
Immunofluorescence (IF) Experiment Service
Buffer
DAB Chromogen Kit
SABC Kit
Long-arm Biotin Labeling Kit
Real Time PCR Experimental Service
Related products
Catalog No. | Organism species: Homo sapiens (Human) | Applications (RESEARCH USE ONLY!) |
EPA899Hu61 | Eukaryotic Osteopontin (OPN) | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA899Hu02 | Recombinant Osteopontin (OPN) | Positive Control; Immunogen; SDS-PAGE; WB. |
EPA899Hu62 | Eukaryotic Osteopontin (OPN) | Positive Control; Immunogen; SDS-PAGE; WB. |
APA899Hu61 | Active Osteopontin (OPN) | Cell culture; Activity Assays. |
PAA899Hu06 | Polyclonal Antibody to Osteopontin (OPN) | WB; IHC; ICC; IP. |
PAA899Hu02 | Polyclonal Antibody to Osteopontin (OPN) | WB; IHC; ICC; IP; FCM |
LAA899Hu71 | Biotin-Linked Polyclonal Antibody to Osteopontin (OPN) | WB; IHC; ICC. |
MAA899Hu22 | Monoclonal Antibody to Osteopontin (OPN) | WB; IHC; ICC; IP. |
SEA899Hu | ELISA Kit for Osteopontin (OPN) | Enzyme-linked immunosorbent assay for Antigen Detection. |
AEA899Hu | ELISA Kit for Anti-Osteopontin Antibody (Anti-OPN) | Enzyme-linked immunosorbent assay for Antibody Detection. |
SCA899Hu | CLIA Kit for Osteopontin (OPN) | Chemiluminescent immunoassay for Antigen Detection. |
LMA899Hu | Multiplex Assay Kit for Osteopontin (OPN) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |
KSA899Hu01 | ELISA Kit DIY Materials for Osteopontin (OPN) | Main materials for "Do It (ELISA Kit) Yourself". |